Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

吡非尼酮抗肿瘤作用机制的研究进展.

Autor: 狄英杰^1,2,3, 薛耀勤² 535106163@qq.com, 任金锐³, 欧爱鑫³, 刘月³

Publikováno v: Chinese Journal of Oncology Prevention & Treatment. Aug2024, Vol. 16 Issue 4, p494-498. 5p.

The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis.

Autor: Saad MI; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia., McLeod L; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia., Yu L; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia., Ebi H; Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Advanced Cancer Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan., Ruwanpura S; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia., Sagi I; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Rose-John S; Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany., Jenkins BJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.

Publikováno v: Carcinogenesis [Carcinogenesis] 2020 Jun 17; Vol. 41 (4), pp. 527-538.

The role of extracellular traps released by neutrophils, eosinophils, and macrophages in asthma.

Autor: Gu, Wei^1,2 (AUTHOR), Huang, Chunli^1,2 (AUTHOR), Chen, Gongqi^1,2 (AUTHOR), Kong, Weiqiang^1,2 (AUTHOR), Zhao, Lu^1,2 (AUTHOR), Jie, Huiru^1,2 (AUTHOR), Zhen, Guohua^1,2 (AUTHOR) ghzhen@tjh.tjmu.edu.cn

Publikováno v: Respiratory Research. 7/30/2024, Vol. 25 Issue 1, p1-13. 13p.

ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.

Autor: Saad MI; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Alhayyani S; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., McLeod L; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Yu L; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Alanazi M; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Deswaerte V; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Tang K; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Jarde T; Cancer Program, Monash Biomedicine Discovery Institute, Clayton, Vic., Australia.; Department of Anatomy and Developmental Biology, Monash University, Clayton, Vic., Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Vic., Australia., Smith JA; Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Clayton, Vic., Australia.; Department of Cardiothoracic Surgery, Monash Health, Clayton, Vic., Australia., Prodanovic Z; Monash Biobank, Monash Health, Clayton, Vic., Australia., Tate MD; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Balic JJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Watkins DN; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia., Cain JE; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Vic., Australia., Bozinovski S; School of Health and Biomedical Sciences, RMIT University, Bundoora, Vic., Australia., Algar E; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Genetics and Molecular Pathology Laboratory, Monash Health, Clayton, Vic., Australia., Kohmoto T; Department of Human Genetics, Tokushima University Graduate School of Medicine, Tokushima, Japan.; Division of Molecular Genetics, Aichi Cancer Center Research Institute, Nagoya, Japan., Ebi H; Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Advanced Cancer Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan., Ferlin W; NovImmune SA, Geneva, Switzerland., Garbers C; Department of Pathology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Ruwanpura S; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia., Sagi I; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Rose-John S; Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany., Jenkins BJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic., Australia brendan.jenkins@hudson.org.au.; Department of Molecular and Translational Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Vic., Australia.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2019 Apr; Vol. 11 (4).